What is Vitruvian?
Founded in 2012 and headquartered in Perth, Western Australia, Vitruvian operates as an integrated fitness technology firm. The company provides a sophisticated platform that utilizes artificial intelligence to adapt exercise routines to the specific needs of individual users in real-time. Through its All Access membership model, Vitruvian offers a comprehensive suite of features, including expert-led classes, goal-oriented programming, and collaborative workout sharing. By integrating advanced data tracking with high-performance hardware, the company has carved out a significant niche in the connected fitness market, catering to users who demand precision and personalization in their health and wellness regimens.
How much funding has Vitruvian raised?
Vitruvian has raised a total of $42M across 2 funding rounds:
Angel/Seed
$6M
Series A
$36M
Angel/Seed (2021): $6M with participation from Ten13 Management and Larsen Ventures
Series A (2023): $36M led by Ten13 Management and Larsen Ventures
Key Investors in Vitruvian
Ten13 Management
TEN13 is an early-stage venture capital firm focused on fueling ambitious founders and investors by investing in Pre-seed to Series A and beyond, particularly in technology-driven startups.
Larsen Ventures
Larsen Ventures is a strategic investment firm that provides capital and operational support to high-growth technology companies looking to disrupt traditional industry verticals.
What's next for Vitruvian?
With the successful closure of this major strategic investment, Vitruvian is well-positioned to accelerate its product development roadmap and enhance its global market reach. The company is expected to focus on deepening its AI capabilities, potentially introducing more granular performance analytics and expanding its library of digital content. Furthermore, the influx of capital will likely support the scaling of its operational infrastructure to meet the rising demand for high-fidelity, data-driven fitness solutions. As Vitruvian continues to refine its platform, the focus will remain on maintaining its competitive edge through continuous innovation and strategic partnerships within the broader health-tech ecosystem.
See full Vitruvian company page
